Pan Quintin, Bao Li Wei, Teknos Theodoros N, Merajver Sofia D
Division of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI 48109, USA.
Cancer Res. 2006 Oct 1;66(19):9379-84. doi: 10.1158/0008-5472.CAN-06-2646.
Over 70% of patients with head and neck squamous cell carcinoma (HNSCC) present with locoregionally advanced stage III and IV disease. In spite of aggressive therapy, locoregional disease recurs in 60% and metastatic disease develops in 15% to 25% of patients causing a major decline in quality and length of life. Therefore, there is a need to identify and understand genes that are responsible for inducing an aggressive HNSCC phenotype. Evidence has shown that protein kinase C (PKC) epsilon is a transforming oncogene and may play a role in HNSCC progression. In this study, we determine the downstream signaling pathway mediated by PKC epsilon to promote an aggressive HNSCC phenotype. RNA interference knockdown of PKC epsilon in UMSCC11A and UMSCC36, two highly invasive and motile HNSCC cell lines with elevated endogenous PKC epsilon levels, resulted in cells that were significantly less invasive and motile than the small interfering RNA-scrambled control transfectants; 51 +/- 5% (P < 0.006) and 49 +/- 3% (P < 0.010) inhibition in invasion and 69 +/- 1% (P < 0.0005) and 66 +/- 3% (P < 0.0001) inhibition in motility, respectively. PKC epsilon-deficient UMSCC11A clones had reduced levels of active and serine-phosphorylated RhoA and RhoC. Moreover, constitutive active RhoA completely rescued the invasion and motility defect, whereas constitutive active RhoC completely rescued the invasion and partially rescued the motility defect of PKC epsilon-deficient UMSCC11A clones. These results indicate that RhoA and RhoC are downstream of PKC epsilon and critical for PKC epsilon-mediated cell invasion and motility. Our study shows, for the first time, that PKC epsilon is involved in a coordinated regulation of RhoA and RhoC activation, possibly through direct post-translational phosphorylation.
超过70%的头颈部鳞状细胞癌(HNSCC)患者就诊时已处于局部晚期III期和IV期疾病。尽管进行了积极治疗,但60%的患者局部疾病会复发,15%至25%的患者会发生转移性疾病,导致生活质量和寿命大幅下降。因此,有必要识别和了解导致侵袭性HNSCC表型的基因。有证据表明,蛋白激酶C(PKC)ε是一种转化癌基因,可能在HNSCC进展中起作用。在本研究中,我们确定了PKCε介导的下游信号通路,以促进侵袭性HNSCC表型。在UMSCC11A和UMSCC36这两种具有高侵袭性和运动性且内源性PKCε水平升高的HNSCC细胞系中,通过RNA干扰敲低PKCε,导致细胞的侵袭性和运动性明显低于小干扰RNA-乱序对照转染细胞;侵袭抑制率分别为51±5%(P<0.006)和49±3%(P<0.010),运动抑制率分别为69±1%(P<0.0005)和66±3%(P<0.0001)。PKCε缺陷的UMSCC11A克隆中活性和丝氨酸磷酸化的RhoA和RhoC水平降低。此外,组成型活性RhoA完全挽救了侵袭和运动缺陷,而组成型活性RhoC完全挽救了侵袭缺陷并部分挽救了PKCε缺陷的UMSCC11A克隆的运动缺陷。这些结果表明,RhoA和RhoC是PKCε的下游,对PKCε介导的细胞侵袭和运动至关重要。我们的研究首次表明,PKCε可能通过直接的翻译后磷酸化参与RhoA和RhoC激活的协调调节。